These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27892716)

  • 21. The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients.
    Muyas F; Rodriguez MJG; Cascão R; Afonso A; Sauer CM; Faria CC; Cortés-Ciriano I; Flores I
    Nat Commun; 2024 Jan; 15(1):82. PubMed ID: 38167290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
    Panier S; Maric M; Hewitt G; Mason-Osann E; Gali H; Dai A; Labadorf A; Guervilly JH; Ruis P; Segura-Bayona S; Belan O; Marzec P; Gaillard PL; Flynn RL; Boulton SJ
    Mol Cell; 2019 Oct; 76(1):27-43.e11. PubMed ID: 31447390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of R-loop structures by phosphorylated hTERT preserves genome integrity.
    Machitani M; Nomura A; Yamashita T; Yasukawa M; Ueki S; Fujita KI; Ueno T; Yamashita A; Tanzawa Y; Watanabe M; Taniguchi T; Saitoh N; Kaneko S; Kato Y; Mano H; Masutomi K
    Nat Cell Biol; 2024 Jun; 26(6):932-945. PubMed ID: 38806647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.
    George SL; Parmar V; Lorenzi F; Marshall LV; Jamin Y; Poon E; Angelini P; Chesler L
    J Exp Clin Cancer Res; 2020 May; 39(1):78. PubMed ID: 32375866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma.
    Yu EY; Cheung IY; Feng Y; Rabie MO; Roboz GJ; Guzman ML; Cheung NV; Lue NF
    Neoplasia; 2019 Jul; 21(7):689-701. PubMed ID: 31128432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. If the cap fits, wear it: an overview of telomeric structures over evolution.
    Fulcher N; Derboven E; Valuchova S; Riha K
    Cell Mol Life Sci; 2014 Mar; 71(5):847-65. PubMed ID: 24042202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highlighting vulnerabilities in the alternative lengthening of telomeres pathway.
    Carson LM; Flynn RL
    Curr Opin Pharmacol; 2023 Jun; 70():102380. PubMed ID: 37149932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative Lengthening of Telomeres in Yeast: Old Questions and New Approaches.
    Musmaker K; Wells J; Tsai MC; Comeron JM; Malkova A
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome maintenance meets mechanobiology.
    Spegg V; Altmeyer M
    Chromosoma; 2024 Jan; 133(1):15-36. PubMed ID: 37581649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase lost?
    Mason JM; Randall TA; Capkova Frydrychova R
    Chromosoma; 2016 Mar; 125(1):65-73. PubMed ID: 26162505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated Understanding of Cancer as a Metabolic and Telomere-Driven Disease, and Proposal for Complex Personalized Treatment, a Hypothesis.
    Muresanu C; Somasundaram SG; Vissarionov SV; Torres Solis LF; Solís Herrera A; Kirkland CE; Aliev G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence polarization assay for screening FANCM-RMI inhibitors to target the alternative lengthening of telomeres.
    Alcock LJ; Sudhakar HK; Young R; Lau YH
    Methods Enzymol; 2024; 698():361-378. PubMed ID: 38886039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The crosstalk between glucose metabolism and telomerase regulation in cancer.
    Huang M; Liu M; Wang R; Man Y; Zhou H; Xu ZX; Wang Y
    Biomed Pharmacother; 2024 Jun; 175():116643. PubMed ID: 38696988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomeres and cancer: from crisis to stability to crisis to stability.
    Campbell PJ
    Cell; 2012 Feb; 148(4):633-5. PubMed ID: 22341437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WRN regulates pathway choice between classical and alternative non-homologous end joining.
    Shamanna RA; Lu H; de Freitas JK; Tian J; Croteau DL; Bohr VA
    Nat Commun; 2016 Dec; 7():13785. PubMed ID: 27922005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A balance between elongation and trimming regulates telomere stability in stem cells.
    Rivera T; Haggblom C; Cosconati S; Karlseder J
    Nat Struct Mol Biol; 2017 Jan; 24(1):30-39. PubMed ID: 27918544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The telomere lengthening conundrum - it could be biology.
    Bateson M; Nettle D
    Aging Cell; 2017 Apr; 16(2):312-319. PubMed ID: 27943596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer.
    Kim W; Ludlow AT; Min J; Robin JD; Stadler G; Mender I; Lai TP; Zhang N; Wright WE; Shay JW
    PLoS Biol; 2016 Dec; 14(12):e2000016. PubMed ID: 27977688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ku Binding on Telomeres Occurs at Sites Distal from the Physical Chromosome Ends.
    Larcher MV; Pasquier E; MacDonald RS; Wellinger RJ
    PLoS Genet; 2016 Dec; 12(12):e1006479. PubMed ID: 27930670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human RECQL1 participates in telomere maintenance.
    Popuri V; Hsu J; Khadka P; Horvath K; Liu Y; Croteau DL; Bohr VA
    Nucleic Acids Res; 2017 Mar; 45(5):2935. PubMed ID: 27923931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.